Last update 29 Nov 2025

Kangxian Duyiwei Biopharmaceutical Co., Ltd.

Subsidiary Company|2014|Gansu Sheng, China|
www.hkmg.com

Overview

Tags

Other Diseases
Urogenital Diseases
Herbal medicine

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Top 5 Drug TypeCount
Herbal medicine1

Related

1
Drugs associated with Kangxian Duyiwei Biopharmaceutical Co., Ltd.
Duyiwei Capsule
Target-
Mechanism-
Active Org.
Kangxian Duyiwei Biopharmaceutical Co., Ltd.
Originator Org.
Kangxian Duyiwei Biopharmaceutical Co., Ltd.
Active Indication
Hemorrhage [+1]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
China
First Approval Date20 Jun 2019
2
Clinical Trials associated with Kangxian Duyiwei Biopharmaceutical Co., Ltd.
ChiCTR2400083198
/ Not yet recruitingPhase 4IIT
A randomized, double-blind, parallel controlled clinical trial to evaluate the efficacy and safety of Duyiwei capsules in the treatment of knee osteoarthritis patients
ChiCTR2400080418
/ Not yet recruitingPhase 4IIT
A multicenter randomized controlled study on the treatment of cervical spondylotic radiculopathy with Duyiwei capsules
100 Clinical Results associated with Kangxian Duyiwei Biopharmaceutical Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Kangxian Duyiwei Biopharmaceutical Co., Ltd.
Login to view more data
100 Deals associated with Kangxian Duyiwei Biopharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Kangxian Duyiwei Biopharmaceutical Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 09 Dec 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Duyiwei Capsule
Hemorrhage
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free